Search for: "Sanofi-Aventis" Results 141 - 160 of 563
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Aug 2016, 9:05 pm by Andrea Tucker
It is manufactured by Sanofi-Aventis, a global pharmaceutical company that has a United States based headquarters in New Jersey. [read post]
7 Apr 2010, 8:59 pm by Ron Coleman
They just filed a lawsuit in California seeking a ruling that an independent online newsletter called AccompliaReport.com devoted to reporting news about Accomplia, a Sanofi-Aventis drug intended to combat obesity and smoking addiction, can continue to use the [...] [read post]
11 Mar 2008, 9:50 pm
Noonan -- Any hopes that Thailand would amend or overrule its policy of ignoring drug patent rights were dashed when the Thai government announced that it intended to maintain its extension of its compulsory licensing policy to four anti-cancer drugs: Novartis' Imatinib ® and Letrozole ®, Sanofi-Aventis' Docetaxel ®, and... [read post]
10 Jan 2010, 6:40 pm by Varun R. Chhonkar
This year at least 20 odd drug molecules will be going off-patent in the United States including (1) Merck’s anti-hypertension molecule Losartan, active ingredient of Cozaar and Hyzaar franchise, (2) Eisai’s anti-dementia molecule Donepezil, active ingredient of Aricept and Aricept ODT (3) Sanofi-Aventis’s anti-cancer molecule Docetaxel, active ingredient of Taxotere franchise, (4) Pfizer’s [read post]
14 May 2007, 12:37 pm
Supreme Court today denied without comment Amgen's petition for certiorari to review the Federal Circuit's reversal (for the second time) of the District Court's construction of the term therapeutically effective amount in its patent infringement suit against Sanofi-Aventis over erythropoietin (EPO). [read post]
2 Feb 2007, 12:16 pm
Despite the enthusiasm of analysts and investors, the rumored acquisition of Bristol-Myers Squibb by Paris-based Sanofi-Aventis is probably a bad idea in the long term, writes Forbes’ Matthew Herper. [read post]
12 Feb 2007, 10:32 am
Shares of Bristol-Myers Squibb declined as much as 4 percent Monday after the Times of London reported over the weekend that its talks to merge with Sanofi Aventis, a deal that would form the world’s No. 2 drugmaker, had been called off. [read post]
31 Jan 2007, 4:36 am
Bristol-Myers Squibb, the drug maker, is beefing up its banking team ahead of possible takeover approaches from rivals, notably Sanofi-Aventis, by retaining the services of three Wall Street banks, The Financial Times reported. [read post]
7 Apr 2007, 11:36 am
In March 2004 when Sanofi-Aventis SA reported data on their "miracle" obesity drug, it attracted instant attention. [read post]
11 Aug 2016, 8:07 pm by Andrea Tucker
It is manufactured by Sanofi-Aventis and used to treat a variety of cancers. [read post]
30 Aug 2016, 6:12 pm by Andrea Tucker
Taxotere (docetaxel) is a drug that is manufactured by Sanofi-Aventis for use in treating a number of different types of cancer. [read post]
5 May 2010, 5:03 am by Mark Zamora
Several European countries have recalled batches of generic heart drug Plavix made at a factory in India.Plavix, or clopidogrel, is sold as a brand by Sanofi-Aventis and Bristol-Myers Squibb and is the world's second biggest-selling medicine, with worldwide sales of more than $9 billion a year.The medicine is off patent in some European markets.Source here. [read post]
29 Jan 2007, 3:58 am
Sanofi-Aventis and Bristol-Myers Squibb could announce a friendly merger deal in the next few weeks to create the world’s largest pharmaceuticals company, according to an unsourced report from French financial newsletter La Lettre de l’Expansion. [read post]
26 Aug 2019, 4:15 am by IPWatchdog
Pfizer saw a lot of success last week in having seven IPRs instituted against Sanofi-Aventis, challenging four injectable insulin treatment patents that are at the center... [read post]
30 Jul 2007, 7:10 pm
Sanofi-Aventis U S LLC et al. v. [read post]
17 Jun 2007, 7:53 pm
Sanofi-Aventis U.S. [read post]